Table of Contents Table of Contents
Previous Page  41 / 398 Next Page
Information
Show Menu
Previous Page 41 / 398 Next Page
Page Background

36

Abstracts

Genetic variations drive the facial appearance. The ease of DNA

analysis can allow the clinician to add an additional aspect to

treatment planning. Including not only analysis for physiologic

and functional parameters, yet also familial/genetic data to

achieve long-term physiologic and surgical success.

This paper will review the history of cephalometrics and

its limited normative values; challenge whether planning (two-

dimensional or 3D) should be performed based on normative or

beautiful numerical analysis; and call together a community of

clinical and technical personnel to establish the next generation of

COGS.

Reference

1 Burstone, C. J., James, R. B., Legan, H., Murphy, G. A., & Norton, L. A.

(1978). Cephalometrics for orthognathic surgery.

J Oral Surg

,

36

, 269–277.

http://dx.doi.org/10.1016/j.ijom.2017.02.130

Minimally invasive salivary gland therapy

M. McGurk

Guy’s Hospital, London, United Kingdom

In the past decade there has been a revolution in the treatment

of benign salivary gland disease. Despite that fact that in most

countries salivary gland adenectomy is the treatment of choice for

the management of salivary gland obstruction, ranulae and benign

tumours, this is no longer necessary.

A description of modern minimally invasive management tech-

nique will be provided. This will involve intra- and extracorporeal

lithotripsy and salivary endoscopy. The results of endoscope-

assisted surgical removal of over 200 submandibular and 100

parotid glands stones will be presented. New minimally invasive

techniques for the management of salivary ranulae with be dis-

cussed and the results over 1000 cases of extra capsular dissection

of parotid tumours will be presented.

http://dx.doi.org/10.1016/j.ijom.2017.02.131

Management of temporomandibular joint-related progressive

facial asymmetries

P. Mehra

Boston University Henry M. Goldman School of Dental

Medicine, Boston, MA, United States

Progressive facial asymmetries often present many challenges for

clinicians. Achieving predictable functional and aesthetic results

in patients with facial asymmetries with orthognathic surgery

requires accurately diagnosing the aetiology responsible for the

dentofacial deformity. The role of the temporomandibular joint

(TMJ) in the development of progressive facial asymmetries can-

not be overemphasised; examples include joint conditions like

condylar hyperplasia and osteochondroma, both of which cause

mandibular overgrowth beyond the usual timeline for cessation

of lower jaw growth. This presentation will provide an overview

of the most common TMJ-related facial deformities and focus on

contemporary principles used in the surgical management of these

complex patients.

http://dx.doi.org/10.1016/j.ijom.2017.02.132

Surgically-assisted orthodontic therapy: an office-based alter-

native for rapid correction of malocclusions

P. Mehra

Boston University Henry M. Goldman School of Dental

Medicine, Boston, MA, United States

Duration and cost of the treatment still remain the biggest

challenges for the orthodontic field in the current era. Typical

orthodontic treatment ranges from 1 to 2 years, which requires

continuous compliance and expense from the patient’s perspec-

tive for a considerable period of time. Although, a relatively new

technique, selective alveolar decortication (SAD) has the potential

to provide a solid platform for improvement in the efficiency and

effectiveness of current-day orthodontic therapy.

Besides increasing the scope of orthodontic treatment, it has-

tens the results of conventional nonsurgical orthodontic therapy

and has the potential to correct certain specific malocclusions

with minimally invasive, office-based surgery. This presentation

details experiences of over 100 patients with this technique and

aims to familiarise the audience with the biophysiology, surgical

considerations, indications, contraindications, and limitations of

SAD.

http://dx.doi.org/10.1016/j.ijom.2017.02.133

Face transplant: long-term outcomes

J.P. Meningaud

University of Paris 12, France

Background:

Over 38 face transplantations have been performed

worldwide since 2005.

Objectives:

The aimof this studywas to give an update of the long-

term outcomes of a series of patients operated in our department

between 2007 and 2011.

Methods:

Outcomes of 7 face allotransplant recipients were

reported on average 6 years after transplantation. All hospi-

talisations except for planned revision surgeries and immuno-

suppressive follow-up therapy were reported as serious adverse

events (SAE). Patient health-related quality of life (HRQoL) was

assessed quantitatively using the Short Form-36 (SF-36) health

questionnaire.

Findings:

In all patients still alive after a long follow-up, the trans-

plants were functional. Of the 7 patients, 2 died: one, 63 days’

post-transplantation due to transplant destruction with concomi-

tant pseudomonas infection and the second by suicide after battling

depression. SAE were related to infection within the first month,

acute rejection from 1 day to 7 years’ post-transplantation, and

to side effects of immunosuppressive therapy. Recurrent rejection

episodes justified maintenance therapy with high-dose steroids in

all patients at the last follow-up visit, yet no patient developed

diabetes. Three patients developed hypertension and a treatment

was needed in one patient. In all patients, a significant reduction

in glomerular filtration rate was noted. All recipients and their

families well accepted their transplant. Improvements in social

integration and HRQoL were highly variable among patients and

depended on baseline levels and psychiatric comorbidities.

Conclusion:

These long-term outcomes highlight the significant

pre-existing psychiatric conditions on the risk/benefit ratio of

facial transplantation.

http://dx.doi.org/10.1016/j.ijom.2017.02.134